Not available
Quote | Alimera Sciences Inc. (NASDAQ:ALIM)
Last: | $3.36 |
---|---|
Change Percent: | -2.43% |
Open: | $3.16 |
Close: | $3.36 |
High: | $3.36 |
Low: | $3.121 |
Volume: | 9,298 |
Last Trade Date Time: | 12/01/2023 03:00:00 am |
News | Alimera Sciences Inc. (NASDAQ:ALIM)
ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces th...
ATLANTA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that cli...
Message Board Posts | Alimera Sciences Inc. (NASDAQ:ALIM)
Subject | By | Source | When |
---|---|---|---|
agreed | The Night Stalker | investorshub | 05/18/2023 2:32:25 PM |
$ALIM I got in for a play | MiamiGent | investorshub | 05/18/2023 1:45:59 PM |
Alimera Acquires U.S. Commercial Rights to YUTIQ | subslover | investorshub | 05/18/2023 12:24:59 PM |
$ALIM best news of the day | whytestocks | investorshub | 05/17/2023 10:09:44 PM |
is it bear time? Or do we go bull? | mick | investorshub | 05/17/2023 8:52:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to...
ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces th...
ATLANTA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to...